These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 19782076)
1. A scanning peptide array approach uncovers association sites within the JNK/beta arrestin signalling complex. Li X; MacLeod R; Dunlop AJ; Edwards HV; Advant N; Gibson LC; Devine NM; Brown KM; Adams DR; Houslay MD; Baillie GS FEBS Lett; 2009 Oct; 583(20):3310-6. PubMed ID: 19782076 [TBL] [Abstract][Full Text] [Related]
2. The beta-arrestin-2 scaffold protein promotes c-Jun N-terminal kinase-3 activation by binding to its nonconserved N terminus. Guo C; Whitmarsh AJ J Biol Chem; 2008 Jun; 283(23):15903-11. PubMed ID: 18408005 [TBL] [Abstract][Full Text] [Related]
3. Structural Mechanism of the Arrestin-3/JNK3 Interaction. Park JY; Qu CX; Li RR; Yang F; Yu X; Tian ZM; Shen YM; Cai BY; Yun Y; Sun JP; Chung KY Structure; 2019 Jul; 27(7):1162-1170.e3. PubMed ID: 31080119 [TBL] [Abstract][Full Text] [Related]
4. Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. McDonald PH; Chow CW; Miller WE; Laporte SA; Field ME; Lin FT; Davis RJ; Lefkowitz RJ Science; 2000 Nov; 290(5496):1574-7. PubMed ID: 11090355 [TBL] [Abstract][Full Text] [Related]
12. Identification of a motif in the carboxyl terminus of beta -arrestin2 responsible for activation of JNK3. Miller WE; McDonald PH; Cai SF; Field ME; Davis RJ; Lefkowitz RJ J Biol Chem; 2001 Jul; 276(30):27770-7. PubMed ID: 11356842 [TBL] [Abstract][Full Text] [Related]
13. Mutations of beta-arrestin 2 that limit self-association also interfere with interactions with the beta2-adrenoceptor and the ERK1/2 MAPKs: implications for beta2-adrenoceptor signalling via the ERK1/2 MAPKs. Xu TR; Baillie GS; Bhari N; Houslay TM; Pitt AM; Adams DR; Kolch W; Houslay MD; Milligan G Biochem J; 2008 Jul; 413(1):51-60. PubMed ID: 18435604 [TBL] [Abstract][Full Text] [Related]
14. Small peptide inhibitor of JNK3 protects dopaminergic neurons from MPTP induced injury via inhibiting the ASK1-JNK3 signaling pathway. Pan J; Li H; Zhang B; Xiong R; Zhang Y; Kang WY; Chen W; Zhao ZB; Chen SD PLoS One; 2015; 10(4):e0119204. PubMed ID: 25856433 [TBL] [Abstract][Full Text] [Related]
15. Identification of arrestin-3-specific residues necessary for JNK3 kinase activation. Seo J; Tsakem EL; Breitman M; Gurevich VV J Biol Chem; 2011 Aug; 286(32):27894-901. PubMed ID: 21715332 [TBL] [Abstract][Full Text] [Related]
16. Mapping binding sites for the PDE4D5 cAMP-specific phosphodiesterase to the N- and C-domains of beta-arrestin using spot-immobilized peptide arrays. Baillie GS; Adams DR; Bhari N; Houslay TM; Vadrevu S; Meng D; Li X; Dunlop A; Milligan G; Bolger GB; Klussmann E; Houslay MD Biochem J; 2007 May; 404(1):71-80. PubMed ID: 17288540 [TBL] [Abstract][Full Text] [Related]
17. β-Arrestin-kinase scaffolds: turn them on or turn them off? Lin A; DeFea KA Wiley Interdiscip Rev Syst Biol Med; 2013; 5(2):231-41. PubMed ID: 23319470 [TBL] [Abstract][Full Text] [Related]
18. Beta-arrestin multimers: does a crowd help or hinder function? DeFea KA Biochem J; 2008 Jul; 413(1):e1-3. PubMed ID: 18537791 [TBL] [Abstract][Full Text] [Related]